For 2026 research planning, the cleanest approach is to treat BPC-157 as a preclinical peptide with promising but uneven evidence, then design protocols around a specific endpoint: tissue remodeling, GI mucosal protection, blood-flow/angiogenesis markers, or neurological model outcomes
Adeva-Andany MM, Calvo-Castro I, Fernndez-Fernndez C, Donapetry-Garca C, Pedre-Pieiro AM
Whether milk thistle preparations should be used over a longer period of time is individual and should be discussed with your doctor beforehand
Junqueira C, Guerrero AT, Galvo-Filho B, Andrade WA, Salgado APC, Cunha TM, et al
[DOI] [PMC free article] [PubMed] [Google Scholar] 12.Gomes A.P., Price N.L., Ling A.J., Moslehi J.J., Montgomery M.K., Rajman L., White J.P., Teodoro J.S., Wrann C.D., Hubbard B.P., et al